| Mr Robert Gale Woodrome, MD | |
|
14006 Old Highway 59 N, Splendora, TX 77372-6302 | |
| (281) 689-6901 | |
| (281) 689-6779 |
| Full Name | Mr Robert Gale Woodrome |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 14006 Old Highway 59 N, Splendora, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265476998 | NPI | - | NPPES |
| 8V4300 | Other | TX | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L1499 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harbor Hospice Of Livingston Lp | Livingston, TX | Hospice |
| Altus Hospice Of North Houston, Lp | The woodlands, TX | Hospice |
| Tyler County Hospital | Woodville, TX | Hospital |
| Chi St Lukes Health Memorial Livingston | Livingston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Woodrome Medical Pa | 3476553579 | 12 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.
Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.
Cutera today announced that it has settled all patent infringement lawsuits with Palomar Medical Technologies, Inc.
Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.
› Verified 1 days ago
| Entity Name | Woodrome Medical Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265460919 PECOS PAC ID: 3476553579 Enrollment ID: O20070112000216 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.
Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.
Cutera today announced that it has settled all patent infringement lawsuits with Palomar Medical Technologies, Inc.
Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.
› Verified 1 days ago
| Entity Name | North Houston Family Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336585397 PECOS PAC ID: 1254655590 Enrollment ID: O20150115001374 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.
Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.
Cutera today announced that it has settled all patent infringement lawsuits with Palomar Medical Technologies, Inc.
Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Gale Woodrome, MD Po Box 1939, Livingston, TX 77351-0037 Ph: (936) 327-9944 | Mr Robert Gale Woodrome, MD 14006 Old Highway 59 N, Splendora, TX 77372-6302 Ph: (281) 689-6901 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.
Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.
Cutera today announced that it has settled all patent infringement lawsuits with Palomar Medical Technologies, Inc.
Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.
› Verified 1 days ago